Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Harnessing the Immune System in Relapsed AML: Dr. Reagan, Rhode Island Hospital

  • Broadcast in Health
HealthTree Podcast for AML

HealthTree Podcast for AML


Follow This Show

If you liked this show, you should follow HealthTree Podcast for AML.

The use of the immune system to treat patients with AML is being heavily pursued as a strategy to more effectively fight AML and give patients with relapsed or refractory disease a better chance at achieving remission or a cure.

Immunotherapy in the form of allogeneic stem cell transplant has been a foundation of curative therapy in AML since the 1970s. While the effectiveness and tolerability of stem cell transplant has improved over the years, significant limitations still exist, warranting the development of new and improved immunotherapy options. 

Join us live September 30th at 12 PM Central to learn from Dr. John Reagan, an AML expert from Rhode Island Hospital, about what steps you can take if you have relapsed or refractory AML. He will be discussing what immunotherapy is, it’s current use in AML and his open clinical trial looking at whether the FDA approved drug Gemtuzumab, followed by an infusion of blood cells called leukocytes from a donor, can stimulate the immune system to potentially fight AML.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled